HIV-1/NN
reactivation/NN
in/IN
resting/VBG
peripheral/JJ
blood/NN
mononuclear/JJ
cells/NNS
of/IN
infected/JJ
adults/NNS
upon/IN
in/FW
vitro/FW
CD4/NN
cross-linking/NN
by/IN
ligands/NNS
of/IN
the/DT
CDR2-loop/NN
in/IN
extracellular/JJ
domain/NN
1/CD
./.

HIV-1/NN
infects/VBZ
resting/VBG
peripheral/JJ
blood/NN
mononuclear/JJ
cells/NNS
(/(
PBMCs/NNS
)/)
but/CC
remains/VBZ
inactive/JJ
state/NN
until/IN
subsequent/JJ
cell/NN
activation/NN
./.
=====
We/PRP
have/VBP
demonstrated/VBN
that/IN
the/DT
cross-linking/NN
of/IN
cell/NN
surface/NN
CD4/NN
by/IN
gp120-anti-gp120/NN
immune/JJ
complexes/NNS
or/CC
heat-inactivated/JJ
HIV-1/NN
(/(
iHIV-1/NN
)/)
is/VBZ
sufficient/JJ
to/TO
trigger/VB
activation/NN
signals/NNS
leading/VBG
to/TO
virus/NN
reactivation/NN
(/(
9/CD
)/)
./.
=====
In/IN
this/DT
study/NN
,/,
we/PRP
demonstrate/VBP
that/IN
NF-kappaB/NN
nuclear/JJ
translocation/NN
and/CC
stimulation/NN
of/IN
virus/NN
production/NN
by/IN
iHIV-1/NN
were/VBD
strictly/RB
linked/VBN
to/TO
the/DT
concentrations/NNS
of/IN
viral/JJ
proteins/NNS
used/VBN
as/IN
exogenous/JJ
stimuli/NNS
./.
=====
Moreover/RB
,/,
we/PRP
further/RB
investigated/VBD
the/DT
physiologic/JJ
relevance/NN
of/IN
these/DT
observations/NNS
./.
=====
When/WRB
submitted/VBN
to/TO
an/DT
in/FW
vitro/FW
CD4/NN
cross-linking/NN
by/IN
iHIV-1/NN
,/,
PBMCs/NNS
from/IN
HIV-1-infected/JJ
patients/NNS
were/VBD
found/VBN
to/TO
produce/VB
virus/NN
./.
=====
This/DT
viral/JJ
reactivation/NN
was/VBD
associated/VBN
with/IN
increased/VBN
NF-kappaB/NN
nuclear/JJ
translocation/NN
in/IN
patients/NNS
'/POS
PBMCs/NNS
./.
=====
Additionally/RB
,/,
virus/NN
reactivation/NN
in/IN
resting/VBG
PBMCs/NNS
infected/VBN
in/FW
vitro/FW
with/IN
HIV-1/NN
was/VBD
found/VBN
to/TO
be/VB
specifically/RB
induced/VBN
by/IN
ligands/NNS
of/IN
the/DT
CDR2-loop/JJ|NN
in/IN
domain/NN
1/CD
(/(
D1/NN
)/)
of/IN
CD4/NN
(/(
virus/NN
envelope/NN
and/CC
anti-CD4/JJ
monoclonal/JJ
antibodies/NNS
)/)
./.
=====
In/IN
contrast/NN
,/,
virus/NN
reactivation/NN
was/VBD
not/RB
observed/VBN
following/VBG
CD4/NN
oligomerization/NN
by/IN
antibodies/NNS
that/WDT
bind/VBP
other/JJ
epitopes/NNS
in/IN
D1/NN
,/,
including/VBG
the/DT
D1/CDR3-loop/NN
./.
=====
Finally/RB
,/,
soluble/JJ
CD4/NN
(/(
sCD4/NN
)/)
prevented/VBD
virus/NN
reactivation/NN
by/IN
D1/CDR2-loop/NN
ligands/NNS
./.
=====
Our/PRP$
results/NNS
indicate/VBP
that/IN
the/DT
signaling/NN
events/NNS
initiated/VBN
in/IN
PBMCs/NNS
by/IN
oligomerization/NN
of/IN
CD4/NN
at/IN
the/DT
D1/CDR2-loop/NN
can/MD
trigger/VB
HIV-1/NN
upregulation/NN
in/IN
infected/JJ
individuals/NNS
./.